US FDA Eliminates Covid Testing Requirements for Pfizer and Merck Medications


Reuters    02 February 2023

On Wednesday, the US Food and Drug Administration (FDA) removed the requirement for a positive test to initiate COVID-19 therapies from Merck & Co., Inc., and Pfizer, Inc.


In December 2021, emergency use authorizations were issued for Paxlovid and Lagevrio pills from Pfizer and Merck for patients with mild-to-moderate COVID who tested positive for the virus and who were in danger of progressing to severe COVID.


However, the FDA insisted that the patients should have a recent diagnosis of mild-to-moderate COVID infection. The health regulator stated that even if a person′s test results are negative or if they have recently been exposed and are exhibiting symptoms, their healthcare practitioners may still diagnose them with COVID.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.